Clinical trial

Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD

NCT03370835

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Metoprolol succinate ER Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carvedilol Normalized identity: carvedilolView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-06-01

PhasePHASE4

Conditions

Pulmonary Disease, Chronic Obstructivecandidate · MONDO: chronic obstructive pulmonary disease

Asthmaverified · MONDO: asthma

Adverse Effect of Beta-adrenoreceptor Antagonistsunresolved

Interventions

Metoprolol succinate ERDRUG

CarvedilolDRUG · verified · RxNorm: carvedilol

Sponsors & collaborators

VA Greater Los Angeles Healthcare Systemlead sponsor

AstraZenecacollaborator

Mapped research locations

Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03370835 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.